DE69607095T2 - Test für lipopolysaccharide Antigene - Google Patents

Test für lipopolysaccharide Antigene

Info

Publication number
DE69607095T2
DE69607095T2 DE69607095T DE69607095T DE69607095T2 DE 69607095 T2 DE69607095 T2 DE 69607095T2 DE 69607095 T DE69607095 T DE 69607095T DE 69607095 T DE69607095 T DE 69607095T DE 69607095 T2 DE69607095 T2 DE 69607095T2
Authority
DE
Germany
Prior art keywords
test
lipopolysaccharide antigens
lipopolysaccharide
antigens
chapso
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69607095T
Other languages
English (en)
Other versions
DE69607095D1 (de
Inventor
Jeanette Elizabeth Brid Menton
Paul Raymond Sheard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alere Switzerland GmbH
Original Assignee
Unilever NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever NV filed Critical Unilever NV
Publication of DE69607095D1 publication Critical patent/DE69607095D1/de
Application granted granted Critical
Publication of DE69607095T2 publication Critical patent/DE69607095T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56927Chlamydia
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/962Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125Digestion or removing interfering materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69607095T 1995-09-14 1996-08-12 Test für lipopolysaccharide Antigene Expired - Lifetime DE69607095T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95306506 1995-09-14

Publications (2)

Publication Number Publication Date
DE69607095D1 DE69607095D1 (de) 2000-04-20
DE69607095T2 true DE69607095T2 (de) 2000-11-02

Family

ID=8221332

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69607095T Expired - Lifetime DE69607095T2 (de) 1995-09-14 1996-08-12 Test für lipopolysaccharide Antigene

Country Status (5)

Country Link
US (1) US6159703A (de)
JP (1) JP3534952B2 (de)
AT (1) ATE190725T1 (de)
DE (1) DE69607095T2 (de)
ES (1) ES2145388T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040018634A1 (en) * 2002-07-29 2004-01-29 Kiamars Hajizadeh Sample-collection and preparation device and method
US7585641B2 (en) * 2003-01-21 2009-09-08 Agdia, Inc. Immunoassay and method of use
US7796266B2 (en) 2004-04-30 2010-09-14 Kimberly-Clark Worldwide, Inc. Optical detection system using electromagnetic radiation to detect presence or quantity of analyte
US7815854B2 (en) 2004-04-30 2010-10-19 Kimberly-Clark Worldwide, Inc. Electroluminescent illumination source for optical detection systems
US20060106117A1 (en) * 2004-11-12 2006-05-18 Kimberly-Clark Worldwide, Inc. Compound and method for prevention and/or treatment of vaginal infections
US7619008B2 (en) * 2004-11-12 2009-11-17 Kimberly-Clark Worldwide, Inc. Xylitol for treatment of vaginal infections
US20060217443A1 (en) * 2005-03-28 2006-09-28 Kimberly-Clark Worldwide, Inc. Method for preventing and/or treating vaginal and vulval infections
US20060223765A1 (en) * 2005-03-30 2006-10-05 Kimberly-Clark Worldwide, Inc. Method for inhibiting and/or treating vaginal infection
US7786176B2 (en) 2005-07-29 2010-08-31 Kimberly-Clark Worldwide, Inc. Vaginal treatment composition containing xylitol
JP6096586B2 (ja) * 2013-05-10 2017-03-15 デンカ生研株式会社 蛍光色素で標識された可視域着色不溶性担体粒子の調製とそれを用いたイムノアッセイ法
DE102014220090B3 (de) * 2014-10-02 2015-10-08 Abf Diagnostics Gmbh Probennahmevorrichtung mit Probenaufarbeitungsfunktion

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760131A (en) * 1986-04-23 1988-07-26 Collagen Corporation Wound-healing composition
US4914041A (en) * 1988-02-12 1990-04-03 Beckman Instruments, Inc. Reagent and method for detecting rheumatoid factor
US4916057A (en) * 1988-02-29 1990-04-10 Kallestad Diagnostics, Inc. Chlamydia assay employing base treatment
GB8820375D0 (en) * 1988-08-26 1988-09-28 Boots Celltech Diagnostics Assay
ES2056378T3 (es) * 1989-04-14 1994-10-01 Unilever Nv Procedimiento de extraccion.
JP3524120B2 (ja) * 1992-05-08 2004-05-10 生化学工業株式会社 前処理剤、前処理方法、前処理された試料による測定法、測定用キット及び試料の判定方法
US5302405A (en) * 1992-08-31 1994-04-12 Campbell Soup Company Method for removing cholesterol and fat from egg yolk by chelation and reduced-cholesterol egg product
EP0608546A3 (en) * 1992-12-22 1995-09-27 Takeda Chemical Industries Ltd Glia activating factor (gaf), antibodies against it and their uses.

Also Published As

Publication number Publication date
ES2145388T3 (es) 2000-07-01
JPH09127110A (ja) 1997-05-16
US6159703A (en) 2000-12-12
DE69607095D1 (de) 2000-04-20
JP3534952B2 (ja) 2004-06-07
ATE190725T1 (de) 2000-04-15

Similar Documents

Publication Publication Date Title
DE69607095D1 (de) Test für lipopolysaccharide Antigene
ATE454163T1 (de) Bakterielle impfstoffe, enthaltend auxotrophe attenuierte listerienstämme, welche heterologe antigene exprimieren
DE69840025D1 (de) Assoziierter antworten
TR199701252T1 (xx) Bir saponin ve bir sterol i�eren a��lar.
ES2124668B1 (es) "nuevosl-arilpirazoles con propiedades plaguicidas.
EP1854808A3 (de) Spezifische monoklonale Antikörper für die extrazelluläre Domäne prostataspezifischer Membranantigene
ATE417275T1 (de) Puffern zur stabilizierung von hcv antigenen
PT807178E (pt) Proteinas de micobacterias, microrganismos que as produzem e suas utilizacoes vacinicas e para a deteccao da tuberculose
DE69620209D1 (de) Testsysteme für sterilisator
PT969873E (pt) Hidrato de carbono glicopeptido antigene multiplo, vacina abrangendo o mesmo e seu uso
AU7267396A (en) Diagnostics and treatments of periodontal disease
HK1017692A1 (en) Endothelial cell proliferation inhibitor and method of use
TR199801027T2 (xx) Epitelyom te�his ve tedavisi i�in y�ntem.
ES2056378T3 (es) Procedimiento de extraccion.
NO954386D0 (no) Elektrokjemiluminescensfremgangsmåte
DE69610948T2 (de) Immunoenzymatisches konjugat, herstellungsverfahren dafür und verwendungen
DE69132144D1 (de) Menschliche phospholipase aktivierender proteinteil
ES2125011T3 (es) Procedimiento inmunologico de la antitrombina iii activada por un glicosaminoglicano, anticuerpos monoclonales correspondientes y su procedimiento de obtencion.
AU3577295A (en) Reagent for the determination of free radicals
MX9704717A (es) Antigeno, anticuerpos y ensayo de diagnostico para la enfermedad de alzheimer.
ATE237000T1 (de) Verfahren zum biologischen abbau von polyorganosiloxanen durch einen mikroskopischen pilz und aufspürungsmethode
EP1097174A4 (de) Antikoagulierender antikörper aus lupus gegen die f1 region von prothrombin
ECSP951605A (es) Fragmentos de anticuerpos monoclonales que tienen actividad inmunosupresora, case ran 4105/171
ATE170292T1 (de) Nachweis von antibiotika
BR0315628A (pt) Geração de ozÈnio mediada por anticorpo ou neutrófilo

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: UNILEVER N.V., ROTTERDAM, NL

8327 Change in the person/name/address of the patent owner

Owner name: INVERNESS MEDICAL SWITZERLAND GMBH, ZUG, CH

8328 Change in the person/name/address of the agent

Representative=s name: MEISSNER, BOLTE & PARTNER GBR, 80538 MUENCHEN